Pneumonia

Wockhardt completes Phase 3 pneumonia study of macrolide antibiotic Nafithromycin WCK 4873

Read more

Investment in novel therapies key priority to tackle AMR: GlobalData

Read more

GSK to begin final-stage trials of respiratory syncytial virus vaccine

Read more

FDA approves Nabriva’s antibiotic for pneumonia

Read more

Experimental MERS vaccine shows promise in animals

Read more